000			02174 a2200637 4500
005			20250515065104.0
264		0	_c20070830
008			200708s 0 0 eng d
022			_a0920-9964
024	7		_a10.1016/j.schres.2007.03.011 _2doi
040			_aNLM _beng _cNLM
100	1		_aGeorge, Mark S
245	0	0	_aA single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia. _h[electronic resource]
260			_bSchizophrenia research _cJul 2007
300			_a42-50 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aAntipsychotic Agents _xadverse effects
650	0	4	_aBrain _xblood supply
650	0	4	_aCross-Over Studies
650	0	4	_aDopamine Agonists _xadverse effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImage Processing, Computer-Assisted
650	0	4	_aInjections, Subcutaneous
650	0	4	_aMagnetic Resonance Imaging
650	0	4	_aMale
650	0	4	_aMemory, Short-Term _xdrug effects
650	0	4	_aMiddle Aged
650	0	4	_aNeuropsychological Tests
650	0	4	_aOxygen _xblood
650	0	4	_aPhenanthridines _xadministration & dosage
650	0	4	_aPilot Projects
650	0	4	_aPsychiatric Status Rating Scales
650	0	4	_aReceptors, Dopamine D1 _xagonists
650	0	4	_aRegional Blood Flow _xdrug effects
650	0	4	_aSchizophrenia _xdiagnosis
650	0	4	_aTreatment Outcome
700	1		_aMolnar, Christine E
700	1		_aGrenesko, Emily L
700	1		_aAnderson, Berry
700	1		_aMu, Qiwen
700	1		_aJohnson, Kevin
700	1		_aNahas, Ziad
700	1		_aKnable, Michael
700	1		_aFernandes, Prabhavathi
700	1		_aJuncos, Jorge
700	1		_aHuang, Xuemei
700	1		_aNichols, David E
700	1		_aMailman, Richard B
773	0		_tSchizophrenia research _gvol. 93 _gno. 1-3 _gp. 42-50
856	4	0	_uhttps://doi.org/10.1016/j.schres.2007.03.011 _zAvailable from publisher's website
999			_c17016103 _d17016103